Showing 1 - 20 results of 38 for search 'S. M. Deyev', query time: 0.06s Refine Results
  1. 1
    Targeted PLGA–Chitosan Nanoparticles for NIR-Triggered Phototherapy and Imaging of HER2-Positive Tumors

    Targeted PLGA–Chitosan Nanoparticles for NIR-Triggered Phototherapy and Imaging of HER2-Positive Tumors by Polina A. Kotelnikova, Victoria O. Shipunova, Sergey M. Deyev

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery

    Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery by Ivan V. Zelepukin, Konstantin G. Shevchenko, Sergey M. Deyev

    Published 2024-05-01
    Get full text
    Article
  3. 3
    Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins

    Clinical possibilities of HER2-positive breast cancer diagnosis using alternative scaffold proteins by O. D. Bragina, V. I. Chernov, S. M. Deyev, V. M. Tolmachev

    Published 2022-10-01
    Get full text
    Article
  4. 4
    Self-assembling complexes of quantum dots and scFv antibodies for cancer cell targeting and imaging.

    Self-assembling complexes of quantum dots and scFv antibodies for cancer cell targeting and imaging. by Tatiana A Zdobnova, Oleg A Stremovskiy, Ekaterina N Lebedenko, Sergey M Deyev

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Comparison of Colorimetric and Fluorometric Chemosensors for Protein Concentration Determination and Approaches for Estimation of Their Limits of Detection

    Comparison of Colorimetric and Fluorometric Chemosensors for Protein Concentration Determination and Approaches for Estimation of Their Limits of Detection by Anastasiya A. Mamaeva, Vladimir I. Martynov, Sergey M. Deyev, Alexey A. Pakhomov

    Published 2022-12-01
    Get full text
    Article
  6. 6
    Possible approach to complex liposomal drug delivery system design

    Possible approach to complex liposomal drug delivery system design by D. A. Bezrukov, T. G. Balandin, S. M. Deyev, V. V. Popenko, A. P. Kaplun

    Published 2006-02-01
    Get full text
    Article
  7. 7
    Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using <sup>99m</sup>Tc-DARPinG3

    Possibilities of predicting the HER2 / neu status in a primary tumor in breast cancer patients using <sup>99m</sup>Tc-DARPinG3 by O. D. Bragina, L. A. Tashireva, V. I. Chernov, S. M. Deyev, V. M. Tolmachev

    Published 2023-01-01
    Get full text
    Article
  8. 8
    Genetically engineered CD80–pMHC-harboring extracellular vesicles for antigen-specific CD4+ T-cell engagement

    Genetically engineered CD80–pMHC-harboring extracellular vesicles for antigen-specific CD4+ T-cell engagement by Irina A. Ishina, Inna N. Kurbatskaia, Azad E. Mamedov, Elena I. Shramova, Sergey M. Deyev, Sergey M. Deyev, Sergey M. Deyev, Kamila S. Nurbaeva, Yury P. Rubtsov, Yury P. Rubtsov, Alexey A. Belogurov, Alexey A. Belogurov, Alexander G. Gabibov, Alexander G. Gabibov, Alexander G. Gabibov, Maria Y. Zakharova, Maria Y. Zakharova

    Published 2024-01-01
    Get full text
    Article
  9. 9
    Data of self-made Taq DNA polymerase prepared for screening purposes

    Data of self-made Taq DNA polymerase prepared for screening purposes by E.V. Konovalova, A.A. Schulga, T.I. Lukyanova, E.J. Woo, S.M. Deyev

    Published 2017-04-01
    Get full text
    Article
  10. 10
    Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy

    Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy by Victoria O. Shipunova, Elena N. Komedchikova, Polina A. Kotelnikova, Maxim P. Nikitin, Sergey M. Deyev

    Published 2023-03-01
    Get full text
    Article
  11. 11
    Neuroblastoma Origin and Therapeutic Targets for Immunotherapy

    Neuroblastoma Origin and Therapeutic Targets for Immunotherapy by Irina V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Sergey M. Deyev, Roman V. Kholodenko

    Published 2018-01-01
    Get full text
    Article
  12. 12
    Peroxidase-like activity of silver nanowires and its application for colorimetric detection of the antibiotic chloramphenicol

    Peroxidase-like activity of silver nanowires and its application for colorimetric detection of the antibiotic chloramphenicol by Polina A. Kotelnikova, Anna M. Iureva, Maxim P. Nikitin, Andrey V. Zvyagin, Sergey M. Deyev, Victoria O. Shipunova

    Published 2022-12-01
    Get full text
    Article
  13. 13
    Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29

    Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29 by O. D. Bragina, V. I. Chernov, A. A. Medvedeva, R. V. Zelchan, M. S. Larkina, S. M. Deyev, V. M. Tolmachev

    Published 2020-08-01
    Get full text
    Article
  14. 14
    Data on characterization of magnetic nanoparticles stabilized with fusion protein of Barstar and C-term part of Mms6

    Data on characterization of magnetic nanoparticles stabilized with fusion protein of Barstar and C-term part of Mms6 by Victoria O. Shipunova, Polina A. Kotelnikova, Ulkar F. Aghayeva, Oleg A. Stremovskiy, Alexey A. Schulga, Maxim P. Nikitin, Sergey M. Deyev

    Published 2018-12-01
    Get full text
    Article
  15. 15
    Synergistic Effect of the Combination of the Recombinant Toxin DARPin-LoPE and PDT against HER2-Positive Breast Cancer In Vitro

    Synergistic Effect of the Combination of the Recombinant Toxin DARPin-LoPE and PDT against HER2-Positive Breast Cancer In Vitro by Liubov V. Krylova, Maria A. Karpova, Alexey A. Shulga, Elena V. Konovalova, Evgenii L. Guryev, Sergey M. Deyev, Irina V. Balalaeva

    Published 2023-03-01
    Get full text
    Article
  16. 16
    Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors

    Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors by Elena I. Shramova, Stepan P. Chumakov, Victoria O. Shipunova, Anastasiya V. Ryabova, Georgij B. Telegin, Andrei V. Kabashin, Sergey M. Deyev, Galina M. Proshkina

    Published 2022-02-01
    Get full text
    Article
  17. 17
    Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier Delivery

    Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier Delivery by Victoria O. Shipunova, Olga A. Kolesnikova, Polina A. Kotelnikova, Vladislav D. Soloviev, Anton A. Popov, Galina M. Proshkina, Maxim P. Nikitin, Sergey M. Deyev

    Published 2021-06-01
    Get full text
    Article
  18. 18
    Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells

    Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpress... by Elena N. Komedchikova, Olga A. Kolesnikova, Ekaterina D. Tereshina, Polina A. Kotelnikova, Anna S. Sogomonyan, Alexey V. Stepanov, Sergey M. Deyev, Maxim P. Nikitin, Victoria O. Shipunova

    Published 2022-12-01
    Get full text
    Article
  19. 19
    Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4

    Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4 by Daniel V. Kalinovsky, Irina V. Kholodenko, Elena V. Svirshchevskaya, Alexey V. Kibardin, Dmitry Yu. Ryazantsev, Fedor N. Rozov, Sergey S. Larin, Sergey M. Deyev, Roman V. Kholodenko

    Published 2023-10-01
    Get full text
    Article
  20. 20
    Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo

    Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo by Victoria O. Shipunova, Vera L. Kovalenko, Polina A. Kotelnikova, Anna S. Sogomonyan, Olga N. Shilova, Elena N. Komedchikova, Andrei V. Zvyagin, Maxim P. Nikitin, Sergey M. Deyev

    Published 2021-12-01
    Get full text
    Article

Search Tools: